Massimo Torlontano
About
Massimo Torlontano is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Massimo Torlontano has authored 44 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Surgery and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Massimo Torlontano's work include Thyroid Cancer Diagnosis and Treatment (24 papers), Pituitary Gland Disorders and Treatments (16 papers) and Thyroid Disorders and Treatments (13 papers). Massimo Torlontano is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (24 papers), Pituitary Gland Disorders and Treatments (16 papers) and Thyroid Disorders and Treatments (13 papers). Massimo Torlontano collaborates with scholars based in Italy, United States and Lebanon. Massimo Torlontano's co-authors include Sébastiano Filetti, Cosimo Durante, Vincenzo Trischitta, Domenico Meringolo, Giuseppe Costante, Dario Tumino, Marco Attard, Iacopo Chiodini, Rocco Bruno and Alfredo Scillitani and has published in prestigious journals such as JAMA, The Journal of Clinical Endocrinology & Metabolism and Osteoporosis International.
In The Last Decade
Massimo Torlontano
43 papers receiving 3.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Massimo Torlontano Italy | 29 | 2.9k | 1.8k | 314 | 307 | 239 | 44 | 3.2k | ||
| Carlos Benbassat Israel | 27 | 1.5k 0.5× | 756 0.4× | 273 0.9× | 237 0.8× | 243 1.0× | 96 | 2.0k | ||
| Michele Klain Italy | 25 | 1.4k 0.5× | 733 0.4× | 261 0.8× | 128 0.4× | 185 0.8× | 97 | 2.1k | ||
| Giovanni Lupoli Italy | 29 | 1.6k 0.6× | 600 0.3× | 354 1.1× | 266 0.9× | 532 2.2× | 92 | 2.5k | ||
| Pedro Weslley Rosário Brazil | 29 | 2.5k 0.9× | 1.5k 0.8× | 319 1.0× | 260 0.8× | 130 0.5× | 162 | 2.7k | ||
| Svante Jansson Sweden | 27 | 962 0.3× | 1.1k 0.6× | 378 1.2× | 279 0.9× | 179 0.7× | 59 | 2.4k | ||
| Jennifer A. Sipos United States | 19 | 1.3k 0.5× | 672 0.4× | 171 0.5× | 286 0.9× | 318 1.3× | 50 | 1.8k | ||
| S. Thomas Bigos United States | 17 | 2.2k 0.8× | 795 0.4× | 209 0.7× | 359 1.2× | 230 1.0× | 25 | 2.5k | ||
| William M Drake United Kingdom | 24 | 1.0k 0.4× | 713 0.4× | 183 0.6× | 85 0.3× | 142 0.6× | 81 | 1.5k | ||
| Tapani Ebeling Finland | 20 | 1.5k 0.5× | 1.0k 0.6× | 417 1.3× | 266 0.9× | 267 1.1× | 46 | 2.2k | ||
| S Tibblin Sweden | 29 | 843 0.3× | 1.2k 0.7× | 427 1.4× | 334 1.1× | 175 0.7× | 77 | 2.4k |
Countries citing papers authored by Massimo Torlontano
Since
Specialization
Citations
This map shows the geographic impact of Massimo Torlontano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Torlontano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Torlontano more than expected).
Fields of papers citing papers by Massimo Torlontano
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Massimo Torlontano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Torlontano. The network helps show where Massimo Torlontano may publish in the future.
Co-authorship network of co-authors of Massimo Torlontano
This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Torlontano. A scholar is included among the top collaborators of Massimo Torlontano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Torlontano. Massimo Torlontano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Giani, Carlotta, Laura Valerio, Alberto Bongiovanni, et al.. (2020). Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer. Thyroid. 31(2). 224–232.
2.
Grani, Giorgio, Rocco Bruno, Giuseppe Lucisano, et al.. (2017). Temporal Changes in Thyroid Nodule Volume: Lack of Effect on Paranodular Thyroid Tissue Volume. Thyroid. 27(11). 1378–1384.
3.
Durante, Cosimo, Teresa Montesano, Marco Attard, et al.. (2012). Long-Term Surveillance of Papillary Thyroid Cancer Patients Who Do Not Undergo Postoperative Radioiodine Remnant Ablation: Is There a Role for Serum Thyroglobulin Measurement?. The Journal of Clinical Endocrinology & Metabolism. 97(8). 2748–2753.
4.
Mastroianno, Sandra, Massimo Torlontano, Alfredo Scillitani, et al.. (2011). Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family. Endocrine. 40(3). 481–485.
5.
Eller-Vainicher, Cristina, Valentina Morelli, Antonio Stefano Salcuni, et al.. (2010). Accuracy of several parameters of hypothalamic–pituitary–adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma. European Journal of Endocrinology. 163(6). 925–935.
6.
Durante, Cosimo, Marco Attard, Massimo Torlontano, et al.. (2010). Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas. The Journal of Clinical Endocrinology & Metabolism. 95(11). 4882–4888.
7.
Eller-Vainicher, Cristina, Valentina Morelli, Antonio Stefano Salcuni, et al.. (2009). Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?. European Journal of Endocrinology. 162(1). 91–99.
8.
Torlontano, Massimo, Cosimo Durante, Isabella Torrente, et al.. (2008). TYPE 2 DEIODINASE POLYMORPHISM (THR92ALA) PREDICTS L-THYROXINE DOSE TO ACHIEVE TARGET TSH LEVELS IN THYROIDECTOMIZED PATIENTS. The Journal of Clinical Endocrinology & Metabolism. 910–913.
9.
Chiodini, Iacopo, Massimo Torlontano, Vincenzo Carnevale, Vincenzo Trischitta, & Alfredo Scillitani. (2008). Skeletal involvement in adult patients with endogenous hypercortisolism. Journal of Endocrinological Investigation. 31(3). 267–276.
10.
Montesano, Teresa, Cosimo Durante, Marco Attard, et al.. (2007). Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer. Biomedicine & Pharmacotherapy. 61(8). 468–471.
11.
Scillitani, Alfredo, Iacopo Chiodini, Salvatore Minisola, et al.. (2002). Global Skeletal Uptake of 99m Tc-Methylene Diphosphonate (GSU) in Patients Affected by Endocrine Diseases: Comparison with Biochemical Markers of Bone Turnover. Osteoporosis International. 13(10). 829–834.
12.
Chiodini, Iacopo, Massimo Torlontano, Vincenzo Carnevale, et al.. (2001). Bone Loss Rate in Adrenal Incidentalomas: A Longitudinal Study. The Journal of Clinical Endocrinology & Metabolism. 86(11). 5337–5341.
13.
Zingrillo, Matteo, Massimo Torlontano, Maria Rosaria Ghiggi, et al.. (2000). Radioiodine and Percutaneous Ethanol Injection in the Treatment of Large Toxic Thyroid Nodule: A Long-Term Study. Thyroid. 10(11). 985–989.
14.
Guglielmi, Giuseppe, Antonio Serio, Saverio Fusilli, et al.. (2000). Age-related changes assessed by peripheral QCT in healthy Italian women. European Radiology. 10(4). 609–614.
15.
Torlontano, Massimo. (1999). Altered Bone Mass and Turnover in Female Patients with Adrenal Incidentaloma: The Effect of Subclinical Hypercortisolism. The Journal of Clinical Endocrinology & Metabolism. 84(7). 2381–2385.
16.
Torlontano, Massimo, Iacopo Chiodini, Mauro Pileri, et al.. (1999). Altered Bone Mass and Turnover in Female Patients with Adrenal Incidentaloma: The Effect of Subclinical Hypercortisolism. The Journal of Clinical Endocrinology & Metabolism. 84(7). 2381–2385.
17.
Zingrillo, Matteo, et al.. (1999). Percutaneous Ethanol Injection May be a Definitive Treatment for Symptomatic Thyroid Cystic Nodules not Treatable by Surgery: Five-Year Follow-Up Study. Thyroid. 9(8). 763–767.
18.
Chiodini, Iacopo, Vincenzo Carnevale, Massimo Torlontano, et al.. (1998). Alterations of Bone Turnover and Bone Mass at Different Skeletal Sites due to Pure Glucocorticoid Excess: Study in Eumenorrheic Patients with Cushing’s Syndrome. The Journal of Clinical Endocrinology & Metabolism. 83(6). 1863–1867.
19.
Zingrillo, Matteo, Leonardo D’Aloiso, Maria Rosaria Ghiggi, et al.. (1996). Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence?. Clinical Endocrinology. 45(2). 201–206.
20.
Tassi, Vittorio, L. Scarnecchia, Maria Teresa Pirro, et al.. (1995). A thyroid hormone receptor β gene polymorphism associated with Graves’ disease. Journal of Molecular Endocrinology. 15(3). 267–272.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Carlos Benbassat Breakdown of academic impact, for papers by Michele Klain Breakdown of academic impact, for papers by Giovanni Lupoli Breakdown of academic impact, for papers by Pedro Weslley Rosário Breakdown of academic impact, for papers by Svante Jansson Breakdown of academic impact, for papers by Jennifer A. Sipos Breakdown of academic impact, for papers by S. Thomas Bigos Breakdown of academic impact, for papers by William M Drake Breakdown of academic impact, for papers by Tapani Ebeling Breakdown of academic impact, for papers by S Tibblin